OncoSil secures TGA approval for pancreatic cancer device

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease

Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer

Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare

Access to genomic testing, not therapy cost, is the biggest challenge

Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer

The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents

Merck to showcase 100+ oncology studies at 2026 ASCO meeting

Highlighting KEYTRUDA & expanding cancer pipeline

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints

The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients

ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre

Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care